Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PAND

Pandion Therapeutics (PAND) Stock Price, News & Analysis

Pandion Therapeutics logo

About Pandion Therapeutics Stock (NASDAQ:PAND)

Key Stats

Today's Range
$60.05
$60.05
50-Day Range
$59.90
$60.28
52-Week Range
$10.28
$62.90
Volume
N/A
Average Volume
355,921 shs
Market Capitalization
$1.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PAND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pandion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PAND Stock News Headlines

China’s message to Trump
Did China just fire shots at America? Last week, in Tiananmen Square, China put on a chilling display of military power. Fighter jets, tanks, AI-guided drones — all paraded under the red flag, in front of Vladimir Putin, Kim Jong Un, and more than two dozen world leaders.tc pixel
Lawsuits News | Today's Latest Stories | Reuters
Pandion Therapeutics, Inc.
See More Headlines

PAND Stock Analysis - Frequently Asked Questions

Pandion Therapeutics, Inc. (NASDAQ:PAND) posted its earnings results on Monday, November, 16th. The company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.44) by $0.07. The company earned $2.63 million during the quarter, compared to analyst estimates of $1 million.

Pandion Therapeutics (PAND) raised $94 million in an IPO on Friday, July 17th 2020. The company issued 5,500,000 shares at a price of $16.00-$18.00 per share. Goldman Sachs, Morgan Stanley, SVB Leerink and BMO Capital Markets served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pandion Therapeutics investors own include Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), eBay (EBAY), Garmin (GRMN) and JD.com (JD).

Company Calendar

Last Earnings
11/16/2020
Today
9/24/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PAND
CIK
N/A
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$970 thousand
Price / Sales
1,827.25
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
29,516,000
Free Float
N/A
Market Cap
$1.77 billion
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:PAND) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners